Skip to content
Continuing Nursing Education

American Society of Addiction Medicine (ASAM) – Treatment of Opioid Use Disorder

ASAM bannerDay: June 6th, 2024
Time: 11:00 AM (EDT)
Location: Zoom
Cost: Free

 

Register for 6/6 Treatment of Opioid Use Disorder Webinar: ASAM eLearning: Treatment of Opioid Use Disorder – University of Washington – Continuing Nursing Education – Thursday, June 6, 2024

Overview

University of Washington Continuing Education is partnering with the American Society of Addiction Medicine for a webinar on 6/6 on the Treatment of Opioid Use Disorder.

This 8-hour virtual live course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices and also provides the required education needed to prescribe buprenorphine.

Please Note: That recent legislation has removed the waiver requirement to prescribe buprenorphine. Some of the course content and descriptions refer to the waiver and we appreciate your patience as we work to update this content. To learn more about federal buprenorphine prescribing regulations, check out Policies Governing Buprenorphine for Opioid Use Disorder.

Target Audience

Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to to prescribe buprenorphine in an office-based setting for opioid use disorder.

This activity addresses the following ACGME Competencies: Patient Care and Medical Knowledge.

Learning Outcomes

Upon completion, learners will be able to:

  1. Identify, assess, and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities
  2. Develop an individualized, patient-centered treatment plan including negotiating treatment goals by evaluating appropriate medication- and psychosocial-based treatment options
  3. Monitor progress and modify treatment plan based on patient needs and progress toward treatment goals
  4. Implement best practices for office systems including team-based care to support treatment with medications for opioid use disorder
  5. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with opioid use disorder and the use of medications to treat opioid use disorder